PVI
ONCE

Pura Vida Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pura Vida Investments’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,589
Closed -$3.35M – 111
2017
Q3 		$3.35M Buy
+37,589
New +$2.85M 0.98% 42

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pura Vida Investments's ONCE Position: Q4 2017 in Review

Pura Vida Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2017, closing a stake of 37,589 shares — an estimated $3.35M sold.

Pura Vida Investments first reported a position in ONCE in Q3 2017 and held it in 1 quarter. The position peaked at $3.35M in Q3 2017. 160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

  • Pura Vida Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Pura Vida Investments sold 37,589 Spark Therapeutics, Inc. Common Stock shares in Q4 2017, an estimated $3.35M.
  • Pura Vida Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Pura Vida Investments's Spark Therapeutics, Inc. Common Stock position peaked at $3.35M in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Pura Vida Investments's 13F filing for Q4 2017, filed 14 Feb 2018.